Home Tags Eribulin mesylate

Tag: Eribulin mesylate

8th World ADC: Morphotek to Present Preclinical Data on MORAb-202

During the upcoming 8th Annual World ADC being held September 20-22, 2017 at the Sheraton San Diego Marina in San Diego, CA, Morphotek®, a...

Eisai’s Subsidiary Morphotek Launches ADC Services

Using its proprietary REsidue-SPEcific Conjugation Technology™, also known as  RESPECT™, combined with the company's eribulin-linker toxin platforms, Morphotek, a subsidiary of Eisai, confirmed the...